Reumatismo

Scope & Guideline

Connecting researchers and practitioners in the world of rheumatology.

Introduction

Immerse yourself in the scholarly insights of Reumatismo with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageItalian
ISSN0048-7449
PublisherPAGEPRESS PUBL
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 1952 to 1977, from 1985 to 2024
AbbreviationREUMATISMO / Reumatismo
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMEDITGROUP, VIA G BELLI, 4, PAVIA 27100, ITALY

Aims and Scopes

The journal 'Reumatismo' aims to provide a comprehensive platform for the dissemination of research in the field of rheumatology, focusing on both clinical and experimental studies. It encompasses a wide range of topics related to rheumatic diseases, their management, and the underlying mechanisms involved.
  1. Clinical Research in Rheumatic Diseases:
    The journal emphasizes clinical studies that explore the diagnosis, treatment, and management of various rheumatic diseases, including rheumatoid arthritis, spondyloarthritis, and systemic lupus erythematosus.
  2. Genetics and Biomarkers:
    There is a focus on genetic studies and biomarker research that aims to improve understanding of the pathophysiology of rheumatic diseases and to personalize treatment strategies.
  3. Patient Quality of Life and Psychosocial Aspects:
    Research on the quality of life of patients with rheumatic conditions, including psychosocial factors that influence disease outcomes and treatment adherence, is a significant area of interest.
  4. Innovative Therapies and Pharmacological Studies:
    The journal publishes studies on new therapeutic approaches, including biologics and small molecules, as well as their real-world effectiveness and safety profiles.
  5. Epidemiological Studies:
    Epidemiological research providing insights into disease prevalence, risk factors, and healthcare utilization among patients with rheumatic diseases is a key focus.
  6. Case Reports and Reviews:
    The journal features case reports and literature reviews that highlight unique clinical presentations, treatment challenges, and advancements in rheumatology.
Recent publications in 'Reumatismo' indicate a dynamic evolution in research themes, reflecting emerging trends and areas of growing importance in the field of rheumatology. These themes underscore the journal's responsiveness to contemporary challenges in patient care and research.
  1. Impact of COVID-19 on Rheumatic Diseases:
    Research exploring the effects of COVID-19 on patients with rheumatic diseases, including complications, treatment adaptations, and vaccine responses, has surged, highlighting the pandemic's relevance in rheumatology.
  2. Personalized Medicine and Targeted Therapies:
    There is an increasing focus on personalized medicine, with studies investigating the efficacy and safety of targeted therapies tailored to individual genetic and phenotypic profiles.
  3. Telemedicine and Remote Patient Monitoring:
    The adoption of telemedicine and digital health technologies for managing rheumatic diseases has gained attention, particularly in the context of improving patient access to care during the pandemic.
  4. Psychosocial Interventions and Quality of Life:
    Emerging themes include the assessment of psychosocial interventions aimed at improving the quality of life and mental health of patients with chronic rheumatic conditions.
  5. Longitudinal Studies and Real-World Evidence:
    There is a growing trend towards longitudinal studies that provide real-world evidence on the long-term outcomes of treatments and the chronic nature of rheumatic diseases.

Declining or Waning

While 'Reumatismo' continues to cover a wide array of topics, certain themes have seen a decline in publication frequency or emphasis over the recent years. This may reflect shifting priorities in rheumatological research or changing clinical practices.
  1. Historical Perspectives on Rheumatology:
    There seems to be a waning interest in historical analyses of rheumatic diseases, as fewer papers focus on historical cases or the evolution of terminology and treatments.
  2. Basic Science and Laboratory Studies:
    Research that primarily focuses on basic science or laboratory studies without direct clinical application appears to be less prevalent, indicating a shift towards more translational and clinical research.
  3. Conventional Therapies:
    There is a noticeable decrease in studies focusing on conventional therapies for rheumatic diseases, such as older non-biologic treatments, as newer therapies gain prominence.
  4. Local or Regional Studies:
    While regional epidemiological studies were once more common, there seems to be a decline in local studies that do not have broader implications or applicability to wider populations.
  5. Non-rheumatological Comorbidities:
    Research on comorbidities not directly related to rheumatic diseases has decreased, suggesting a narrowed focus on primary rheumatological conditions and their direct management.

Similar Journals

Open Access Rheumatology-Research and Reviews

Transforming Rheumatology Research through Accessibility.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Exploring New Horizons in Rheumatology Science
Publisher: TAYLOR & FRANCIS LTDISSN: 0300-9742Frequency: 6 issues/year

The Scandinavian Journal of Rheumatology, published by Taylor & Francis Ltd, is a prestigious peer-reviewed journal dedicated to advancing research in the fields of rheumatology, immunology, and related disciplines. With an ISSN of 0300-9742 and an E-ISSN of 1502-7732, this journal has established itself as a vital platform for disseminating significant findings and innovative approaches in the management of rheumatic diseases since its inception in 1959. As a recognized scholarly outlet, it currently resides within the Q2 category for Medicine (miscellaneous) and ranks #39 out of 73 in Rheumatology according to the 2023 Scopus assessments. This reflects the journal's commitment to high-quality research and its relevance in the scientific community. Although it does not provide Open Access options, the journal's rigorous selection process ensures that only the most impactful research reaches its audience, making it a crucial resource for researchers, clinicians, and students engaged in the exploration of rheumatological and immunological challenges. The journal's broad scope encompasses ongoing studies, clinical trials, and reviews that aim to enhance understanding and treatment of rheumatic conditions, promoting collaboration and knowledge-sharing among professionals in the field.

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Advances in Rheumatology

Fostering collaboration for cutting-edge rheumatological advancements.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Empowering Professionals Through Cutting-edge Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1076-1608Frequency: 8 issues/year

JCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Fostering innovation for better patient outcomes.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

Reumatologia

Pioneering research for a healthier tomorrow.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Acta Reumatologica Portuguesa

Fostering a community of knowledge in rheumatic diseases.
Publisher: PUBLISAUDE-EDICOES MEDICAS LDAISSN: 0303-464XFrequency: 4 issues/year

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

Lupus Science & Medicine

Pioneering insights into lupus and autoimmune diseases.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Reumatologia Clinica

Exploring breakthroughs in clinical rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.